Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy
between this translated document and the Japanese original, the original shall prevail.

July 31, 2024

Consolidated Financial Results
for the Three Months Ended June 30, 2024
(Under Japanese GAAP)
Company name: Taoka Chemical Co., Ltd.
Listing:
Tokyo Stock Exchange
Securities code: 4113
URL:
https://www.taoka-chem.co.jp
Representative: Yasuaki Sasaki, President
Inquiries:
Hiroyuki Tanaka, General Manager, Business Services OfficeTelephone:+81-6-7639-7400
Scheduled date to commence dividend payments:–Preparation of supplementary material on financial results:
None
Holding of financial results briefing:
None(Yen amounts are rounded to millions, unless otherwise noted.)

1. Consolidated financial results for the three months ended June 30, 2024 (from April 1,2024 to June 30, 2024)(1) Consolidated operating results (cumulative)
Sales revenue
Three months ended

Millions ofyen%

7,598
7,427

2.3
(8.8)

June 30, 2024
June 30, 2023
Note: Comprehensive income(Percentages indicate year-on-year changes.)

Operating incomeOrdinary income

Net income
attributable toowners of theparent

Millions ofyen

Millions ofyen

Millions ofyen%

511－
3 (98.6)%552－
29 (87.1)

406－28 (78.9)

For the three months ended June 30, 2024: ¥441 million [710.0%]
For the three months ended June 30, 2023: ¥54 million [(66.0)%]

Net income
per share

Diluted net income
per share

Three months ended
June 30, 2024

Yen

Yen

28.31

－June 30, 2023

1.94－%

(2) Consolidated financial position
Total assets
As ofJune 30, 2024
March 31, 2024

Equity-to-assetratio

Net assets

Millions of yen

Millions of yen%

29,92429,72017,522
17,211

58.6
57.9

Reference: Equity
As of June 30, 2024:
As of March 31, 2024:¥17,522 million¥17,211 million

2. Cash dividends
Annual dividends per share
SecondThird
Fiscal yearquarter-end
quarter-endendFirst
quarter-end
Fiscal year ended
March 31, 2024
Fiscal year ending
March 31, 2025
Fiscal year ending
March 31, 2025
(Forecast)

Total

Yen

Yen

Yen

Yen

Yen－

9.00

－

9.00

18.00

9.00

－

9.00

18.00

－Note: Revisions to the forecasts of cash dividends most recently announced: None

3. Consolidated financial forecasts for the fiscal year ending March 31, 2025(from April 1,2024 to March 31, 2025)(Percentages indicate year-on-year changes.)

Operating income Ordinary income

Net income
attributable toowners of theparent%

Millions ofyen%%Millions ofyen%yen

15,000 1.3

700

22.1

720 16.0

500

8.7

34.89

30,000 5.1

1,200

11.6

900

9.7

62.81

Sales revenue
Millions ofyen

Secondquarter-end(Cumulative)
Full year

Millions ofyen

1,250

9.5

Note: Revisions to the forecasts of consolidated financial results most recently announced: NoneNet
incomeper share* Notes(1) Significant changes in the scope of consolidation during the period: None
(2) Adoption of accounting treatment specific to the preparation of quarterly consolidated financialstatements: None
(3) Changes in accounting policies, changes in accounting estimates, and restatement(i) Changes in accounting policies due to revisions to accounting standards and otherregulations: None(ii) Changes in accounting policies due to other reasons: None(iii) Changes in accounting estimates: None(iv) Restatement: None
(4) Number of issued shares (common shares)(i) Total number of issued shares at the end of the period (including treasury shares)
As of June 30, 2024
As of March 31, 2024

14,440,000 shares
14,440,000 shares(ii) Number of treasury shares at the end of the period
As of June 30, 2024
As of March 31, 2024

111,235 shares
111,235 shares(iii) Average number of shares outstanding during the period (cumulative from the beginning of
the fiscal year)
Three months ended June 30, 2024
Three months ended June 30, 2023

14,328,765 shares
14,328,860 shares* Review of quarterly consolidated financial statements conducted by certified public accountants
or an audit corporation: None
* Proper use of earnings forecasts, and other special matters(Caution regarding forward-looking statements and others)
The forward-looking statements, including financial forecasts, contained in this report are based on
information currently available to the Company and certain assumptions deemed to be reasonable.
Accordingly, they are not intended to be construed as assurance that they will be accomplished inthe future. Note that actual results may differ materially from the forecasts for a number of reasons.
(Regarding changes in the presentation unit of amounts and the treatment of fractions)
Amounts in quarterly consolidated financial statements and notes to them are stated in units ofmillions of yen from the first quarter of the fiscal year under review, although they were stated inunits of thousands of yen in the past. For easy comparison, figures as of March 31, 2024, and thosefor the first quarter of the previous fiscal year have been restated in units of millions of yen.
In addition, amounts are rounded to the nearest million from the first quarter of the fiscal year underreview, although they were rounded down to millions in the past. As a result of the change, figures
as of March 31, 2024, and those for the first quarter of the previous fiscal year have been rounded
to the nearest million.

The Taoka Chemical Group’s consolidated sales revenue for the three months ended June 30, 2024,
increased by ¥172 million compared with the same period of the previous fiscal year, to ¥7,598
million. The Group posted operating income of ¥ 511 million, ordinary income of ¥ 552 million andnet income attributable to owners of the parent of ¥ 406 million.
The financial results of Taoka Chemical by business segment for the three months period were as
follows:
Division

Three Months Ended Three Months Ended
June 30, 2023
June 30, 2024

ChangeMillions of Composition Millions of Composition Millions of Year-on-yearyen
ratio (%)
yenratio (%)
yenrate (%)

Fine Chemicals
Functional Chemicals
Functional Polymers andAdditives
Chemicals Segment
Analytical Services
Total

3,616

48.7

3,502

46.1

(114)

(3.2)

860

11.6

889

11.7

29

3.4

2,815

37.93,057

40.2

242

8.6

7,291

98.2

7,448

98.0

157

2.2

136

1.8

151

2.0

14

10.5

7,427

100.0

7,598

100.0

172

2.3

Chemicals Segment
Sales revenue of this segment was ¥7,448 million, a ¥157million increase compared to the same
period of the previous fiscal year.
Fine Chemicals Division
Shipments of agrochemical intermediates decreased. As a result, the division sales revenue
decreased by ¥114 million, to ¥3,502 million.
Functional Chemicals Division
Shipments of rubber additives increased. As a result, the division sales revenue increased by ¥29million, to ¥889 million.
Functional Polymers and Additives Division
Shipments of varnish increased. As a result, the division sales revenue increased by ¥242 million,to ¥3,057 million.
Analytical Services Segment
Sales of soil analysis and asbestos analysis increased. As a result, the segment sales revenue
increased by ¥14 million, to ¥151 million.